SecBot SecBot
6-K ·Filed Nov 2, 2026

GSK

GSK plc
NEUTRAL
Impact 1/10
Horizonimmediate Processed14d 12h ago SEC0001654954-26-009362
Notable filing: 6-K
Actionable Insight • Neutral

No trading signal from this filing. The voting rights count is a standard periodic update with no change in share structure or corporate action.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$49.13
T+0 close · Nov 2, 2026 · via day close
Latest settled
+4.91%
T+5 · $51.54 · next T+20 in 14d
Vs SPY
+4.83%
α at T+5
Latest observation
+5.54%
T+9 · FF3 residual α
  1. T+0 · Nov 2 $49.13entry
  2. T+1 · 14d ago −0.88%α −1.17% · $48.70
  3. T+5 · 8d ago +4.91%α +4.83% · $51.54
  4. T+10 · todayOpen
  5. T+20 · in 14d Pending
  6. T+60 · in 2mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

GSK filed a routine total voting rights notification under UK disclosure rules, reporting 4,045,439,182 voting rights as of 31 October 2026. No financial results, guidance, or material operational updates were included.

Key Facts

  • Issued share capital as of 31 October 2026: 4,316,320,246 ordinary shares
  • Shares held in treasury: 270,881,064
  • Total voting rights: 4,045,439,182
  • Filing is a routine regulatory notification under FCA Disclosure Guidance and Transparency Rule 5.6.1R

Financial Impact

No financial impact; administrative disclosure only

Risk Factors

  • document contains text addressed to automated readers

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
47% bullish (34 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001654954-26-009362
Document: 0001654954-26-009362-index-headers.html0001654954-26-009362
Document: 0001654954-26-009362-index.html0001654954-26-009362
Document: 0001654954-26-009362.txt0001654954-26-009362
Earnings Context (Synthetic; results releases only)0001654954-26-009362

Track record

64 reports on GSK

Performance horizon

9 of 18 bullish or bearish reports moved the stock their way by T+20. Best: +9.35% at T+60 after the Jul 17, 2026 report. 15 of 21 went positive at some point.

Filters
  1. Nov 13, 20263d ago 6-K Neutral 4/10 Entry $50.45 Now $50.41 −0.08% settles Dec 14
  2. Nov 12, 20264d ago 6-K Neutral 2/10 Entry $50.64 Now $50.41 −0.45% settles Dec 11
  3. Nov 6, 202610d ago 6-K Neutral 1/10 Entry $50.33 Now $50.41 +0.16% settles Dec 7
  4. Nov 2, 202614d ago 6-K Neutral 1/10 Viewing Entry $49.13 Now $50.41 +2.61% settles Dec 1
  5. Oct 28, 202619d ago 6-K Neutral 5/10 Entry $48.74 Now $50.41 +3.43% settles Nov 25
  6. Oct 26, 202621d ago 6-K Bullish 5/10 Entry $51.10 Now $50.41 −1.35% settles Nov 23
  7. Oct 26, 202621d ago 6-K Neutral 1/10 Entry $51.10 Now $50.41 −1.35% settles Nov 23
  8. Oct 26, 202621d ago 6-K Bullish 5/10 Entry $51.10 Now $50.41 −1.35% settles Nov 23
  9. Oct 26, 202621d ago 6-K Neutral 4/10 Entry $51.10 Now $50.41 −1.35% settles Nov 23
  10. Oct 21, 202626d ago 6-K Bullish 7/10 Entry $50.02 Now $50.41 +0.78% settles Nov 18
Showing 10 of 64

US Market Status

Market Closed · Opens Wed (10h 14m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 2, 2026